Atraric acid (Synonyms: Methyl atrarate) |
Catalog No.GC66207 |
아트라릭산(메칠 아트라레이트)은 항염증 및 항암 효과가 있는 특정 안드로겐 수용체(AR) 길항제입니다. 821d96072c2d58d8970e76f526b0f6b8Atraric acid는 LNCaP 및 C4-2 세포 모두에서 내인성 전립선 특이 항원 유전자의 발현을 억제합니다. 821d96072c2d58d8970e76f526b0f6b8Atraric acid는 또한 NO와 사이토카인의 합성을 억제하고 MAPK-NFκB 신호 전달 경로를 억제할 수 있습니다. 821d96072c2d58d8970e76f526b0f6b8Atraric acid는 전립선 질환 및 염증성 질환을 연구하는 데 사용할 수 있습니다.821d96072c2d58d8970e76f526b0f6b8
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 4707-47-5
Sample solution is provided at 25 µL, 10mM.
Atraric acid (Methyl atrarate) is a specific androgen receptor (AR) antagonist with anti-inflammatory and anticancer effects. Atraric acid represses the expression of the endogenous prostate specific antigen gene in both LNCaP and C4-2 cells. Atraric acid can also inhibit the synthesis of NO and cytokine, and suppress the MAPK-NFκB signaling pathway. Atraric acid can be used to research prostate diseases and inflammatory diseases[1][2].
Atraric acid (10 μM; CV1 cells) represses the transactivation function mediated by Dihydrotestosterone-induced human AR[1].
Atraric acid (10 μM; PCa cells) inhibits the expression of the PSA gene in both androgen-dependent and androgen-independent PCa cells[1].
Atraric acid (1-300 μM; 24 h) dose-dependently inhibits pro-inflammatory cytokine, nitric oxide, prostaglandin E2 in LPS-stimulated RAW264.7 cells, but does not influence the cell viability[2].
Atraric acid (100 and 300 μM; 18 h or 4 h) downregulates the expression of phosphorylated IκB, extracellular signal-regulated kinases (ERK) and nuclear factor kappa B (NFκB) signaling pathway to exhibit anti-inflammatory effects in LPS-stimulated RAW264.7 cells[2].
Cell Viability Assay[2]
Cell Line: | RAW264.7 cells |
Concentration: | 1-300 μM |
Incubation Time: | 24 h |
Result: | Did not influence the cell viability. |
Western Blot Analysis[2]
Cell Line: | RAW264.7 cells |
Concentration: | 100 and 300 μM |
Incubation Time: | 18 h or 4 h |
Result: | Inhibited LPS-Induced expression of iNOS and COX-2 in a dose-dependent manner. Suppressed LPS-stimulated phosphorylation of the Nfκb signaling pathway. |
Atraric acid (10, 30 mg/kg; i.p.; single dosage) inhibits the production of pro-inflammatory cytokines and reduces pathological damages in LPS-induced endotoxin shock mice[2].
Animal Model: | Female BALB/c mice (7 weeks old, 17-20 g; LPS-induced endotoxin shock)[2] |
Dosage: | 10, 30 mg/kg |
Administration: | i.p.; single dosage |
Result: | Inhibited the production of pro-inflammatory cytokines. Reduced pathological damages such as vasodilation and bleeding. |
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *